Clinical Trial Update: Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating cyclophosphamide, abatacept, and tacrolimus for prevention of graft-versus-host disease; the study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Abatacept (abatacept)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: NYU Langone Health | Conditions: Graft Vs Host Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING